Antoni Sicras Mainar (Antoni Sicras-Mainar)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Chronic Obstructive Pulmonary Disease

Pain Management

Hepatitis C Virus Infection

Top Venues

International journal of chronic obstructive pulmonary disease

Clinical drug investigation

Rheumatology and therapy

Therapeutic advances in musculoskeletal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Josep Comín Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchía, María Isabel Del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sánchez
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol. Journal of comparative effectiveness research (2023)
Alberto Cordero-Fort, Regina Dalmau González-Gallarza, Lluis Masana, Valentín Fuster, Jose Mª Castellano, José Emilio Ruiz Olivar, Ilonka Zsolt, Antoni Sicras Mainar, Jose Ramón González Juanatey
Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Antoni Sicras Mainar, Juan Carlos Tornero-Tornero, Francisco Vargas-Negrín, Isabel Lizarraga, Aram Sicras-Navarro, Javier Rejas-Gutierrez
Sick Leave and Costs in Active Workers with Chronic Osteoarthritis Pain in Spain: Outcomes of the OPIOIDS Real World Study. Open access rheumatology : research and reviews 14 (2022)
Antoni Sicras Mainar, Belén Gómez Rodríguez, Susana Traseira-Lugilde, Toni Fernández-Sánchez, José Luis Velasco Garrido
Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study. BMJ open 12 (4) (2022)
Victoria Neches, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, Antoni Sicras Mainar, Aram Sicras-Navarro, Cruz González, Rafael Cuervo, Soham Shukla, Marcos García-Peñuela
Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain. International journal of chronic obstructive pulmonary disease 17 (2022)
Narcís Cardoner, Antoni Sicras Mainar, Javier Rejas-Gutierrez, Beatriz Armada
Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study. Clinical drug investigation 41 (12) (2021)
Antoni Sicras Mainar, Javier Rejas-Gutierrez, Francisco Vargas-Negrín, Juan Carlos Tornero-Tornero, Aram Sicras-Navarro, Isabel Lizarraga
Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study. Rheumatology and therapy 8 (1) (2021)
Antoni Sicras Mainar, Ramón Morillo-Verdugo
Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection. The Journal of international medical research 48 (10) (2021)
Antoni Sicras Mainar, Francisco José de Abajo, José Luis Izquierdo
Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. International journal of chronic obstructive pulmonary disease 15 (2020)
Antoni Sicras Mainar, Carlos Tornero-Tornero, Francisco Vargas-Negrín, Isabel Lizarraga, Javier Rejas-Gutierrez
Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study. Therapeutic advances in musculoskeletal disease 12 (2020)